Michael Bowen

NHMRC Doherty Biomedical Fellow and Senior Lecturer, University of Sydney

Dr Bowen is an Australian National Health & Medical Research Council Doherty Biomedical Fellow and Senior Lecturer at the University of Sydney’s Brain and Mind Centre. His research uses cutting-edge cellular and preclinical techniques to discover and develop novel pharmacotherapies for serious brain disorders that currently lack effective treatments. Some of his most important work involves the discovery and development of novel pharmacological treatments targeting the brain oxytocin system that are aimed at substance-use disorders and social disorders, such as autism. In other ongoing work, he is exploring the utility of targeting extrasynaptic GABAA receptors to treat a number of neurological and mental health disorders. More recently, he has joined the leadership team of the Lambert Initiative for Cannabinoid Therapeutics, which is exploring the therapeutical potential of cannabinoids for a range of disorders.

Quiénes somos

Participe en el Foro

  • Iniciar sesión
  • Asóciese con nosotros
  • Conviértase en miembro
  • Regístrese para recibir nuestras notas de prensa
  • Suscríbase a nuestros boletines
  • Contacte con nosotros

Enlaces directos

Ediciones en otros idiomas

Política de privacidad y normas de uso

Sitemap

© 2024 Foro Económico Mundial